Hypogonadotropic hypogonadism: genes and variants
Explore variant evidence for Hypogonadotropic hypogonadism across 3 analyzed proteins (FGFR1, CHD7, FSHR). Linked ClinVar records include 2 pathogenic or likely pathogenic variants, 5 variants of uncertain significance and 1 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Hypogonadotropic hypogonadism
FGFR1: Fibroblast growth factor receptor 1
Its fibroblast-growth-factor signaling controls proliferation, differentiation, migration, and developmental patterning in many tissues. Germline pathogenic variants can cause hypogonadotropic hypogonadism or craniosynostosis syndromes, while fusions and other activating alterations drive selected cancers.
2 ClinVar pathogenic / likely pathogenic and 5 uncertain variants in FGFR1 have source records linked to Hypogonadotropic hypogonadism. Association strength is not clinical gene validity.
CHD7: ATP-dependent chromatin remodeler CHD7
It regulates chromatin accessibility and developmental gene programs across multiple embryonic tissues. Haploinsufficiency is the major cause of CHARGE syndrome, which can affect the eyes, heart, choanae, growth, genital development, ears, and nervous system.
0 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in CHD7 have source records linked to Hypogonadotropic hypogonadism. Association strength is not clinical gene validity.
FSHR: Follicle-stimulating hormone receptor
FSH signaling through this pathway drives ovarian follicle maturation and supports Sertoli-cell function and spermatogenesis. Loss-of-function variants can cause ovarian resistance or infertility, whereas activating variants can produce inappropriate ovarian responsiveness.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in FSHR have source records linked to Hypogonadotropic hypogonadism. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): SOX10.
ClinVar pathogenic and likely pathogenic variants linked to Hypogonadotropic hypogonadism
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| FGFR1 D133H | 133 | Extracellular | Pathogenic / likely pathogenic (★★) |
| FGFR1 D224H | 224 | Ig-like C2-type 2 | Pathogenic / likely pathogenic (★★) |
Same protein, different disease
- Hypogonadotropic hypogonadism 2 with or without anosmia also has ClinVar records linked to FGFR1 variants; they fall mostly in different places as the Hypogonadotropic hypogonadism variants (55 pathogenic / likely pathogenic).
- Pfeiffer syndrome also has ClinVar records linked to FGFR1 variants; they fall mostly in different places as the Hypogonadotropic hypogonadism variants (18 pathogenic / likely pathogenic).
- Hartsfield-Bixler-Demyer syndrome also has ClinVar records linked to FGFR1 variants; they fall mostly in different places as the Hypogonadotropic hypogonadism variants (13 pathogenic / likely pathogenic).
- Jackson-Weiss syndrome also has ClinVar records linked to FGFR1 variants; they fall mostly in different places as the Hypogonadotropic hypogonadism variants (5 pathogenic / likely pathogenic).
- Osteoglophonic dysplasia also has ClinVar records linked to FGFR1 variants; they fall mostly in different places as the Hypogonadotropic hypogonadism variants (5 pathogenic / likely pathogenic).
Diseases related to Hypogonadotropic hypogonadism
- Hypogonadotropic hypogonadism 2 with or without anosmia, also linked to FGFR1
- CHARGE syndrome, also linked to CHD7
- Pfeiffer syndrome, also linked to FGFR1
- Wiedemann-Steiner syndrome, also linked to CHD7
- Colorectal cancer, also linked to FGFR1
- Non-small cell lung carcinoma, also linked to FGFR1
- Hartsfield-Bixler-Demyer syndrome, also linked to FGFR1
- Idiopathic pulmonary fibrosis, also linked to FGFR1
- CHD7-related CHARGE syndrome, also linked to CHD7
- Jackson-Weiss syndrome, also linked to FGFR1
- Joubert syndrome, also linked to CHD7
- Hypogonadotropic hypogonadism 5 with or without anosmia, also linked to CHD7
Frequently asked questions
Which genes have records linked to Hypogonadotropic hypogonadism?
This view contains 3 analyzed proteins: FGFR1, CHD7, FSHR. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 2 pathogenic or likely pathogenic variants, 5 variants of uncertain significance and 1 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 9 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center